Published in Radiobiologiia on June 27, 1991
Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells. J Clin Invest (1994) 0.79
Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence. Springerplus (2014) 0.76
Comparative efficacy and the window of radioprotection for adrenergic and serotoninergic agents and aminothiols in experiments with small and large animals. J Radiat Res (2014) 0.75
Embryonic stem cells derived from morulae, inner cell mass, and blastocysts of mink: comparisons of their pluripotencies. Mol Reprod Dev (1993) 0.96
[Different predisposition to the development of spontaneous and induced liver tumors in mice of different strains and their hybrids]. Eksp Onkol (1990) 0.95
Non-random inactivation of the X-chromosome in interspecific hybrid voles. Genet Res (1987) 0.86
Inherited enhancement of hydroxyl radical generation and lipid peroxidation in the S strain rats results in DNA rearrangements, degenerative diseases, and premature aging. Biochem Biophys Res Commun (1994) 0.85
[Reciprocal differences in the susceptibility to induction by ortho-aminoazotoluene of liver and vascular tumors in A/HeJ and CC67BR/Mv mice]. Eksp Onkol (1990) 0.81
[Ratio of spontaneous and o-aminoazotoluene-induced hepatocarcinogenesis in mice]. Eksp Onkol (1985) 0.80
[Comparative effectiveness of antioxidant melatonin and radioprotectors indralin and phenylephrine in local radiation injuries]. Radiats Biol Radioecol (2004) 0.79
[Chondromas (enchondroma, periosteal chondroma, enchondromatosis)]. Arkh Patol (2007) 0.79
[Chondromyxoid fibroma]. Arkh Patol (2007) 0.78
[Radioprotective properties of a radioprotector of emergency action indraline at its adminisration after irradiation in conditions of local shielding of a rat abdomen]. Radiats Biol Radioecol (2008) 0.78
[Pharmacologic analysis of the radiation-protecting effect of indraline]. Radiats Biol Radioecol (2001) 0.78
[Status of the human DNA papillomavirus in cervical tumors]. Mol Biol (Mosk) (2001) 0.78
Effect of radioprotector indralin on carboplatinum hemotoxicity. Bull Exp Biol Med (2006) 0.78
[Effect of cystamine on the performance of human operators]. Kosm Biol Aviakosm Med (1976) 0.77
[Studies of the radiation-protective effects of indralin on the hematopoietic system of different species of animals]. Radiats Biol Radioecol (1996) 0.77
[Effect of indralin on genetic disruption induced by radiation in mice]. Genetika (2003) 0.77
[Combined effect of quercetin and indralin (B-190) in alleviating carboplatin hematologic toxicity]. Vopr Onkol (2012) 0.77
[Chondrosarcoma of the larynx]. Arkh Patol (2008) 0.77
[The role of the vasoconstrictor effect in realizing the radioprotective properties of indralin in experiments on dogs]. Radiats Biol Radioecol (1997) 0.77
[The effect of acetylsalicylic acid on the development of infarct-like myocardial necroses experimentally induced in rats by a single administration of novodrin (isopropylnoreadrenaline)]. Biull Eksp Biol Med (1975) 0.77
[Radioprotective capacity of indralin in reducing radiation injury to salivary glands]. Radiats Biol Radioecol (2004) 0.77
[Mechanism of the radiation-protective effect of indralin]. Radiats Biol Radioecol (1996) 0.77
[Humic substances: pharmacological properties, mechanisms of action, and prospects for use in medicine]. Eksp Klin Farmakol (2010) 0.77
[Relation between the anti-radiation activity of aminothiols (cystamine), the dose of the preparation and the duration of its use under various conditions of gamma-irradiation]. Radiobiologiia (1970) 0.76
[Characteristics of the role of the hydroxyl group in serotonin in the pharmacological and antiradiation effect of serotonin]. Radiobiologiia (1984) 0.76
Effect of melatonin, ascorbic acid, and succinic acid on the cumulative toxic effect of repeated treatment with gammafos (amifostine). Bull Exp Biol Med (2004) 0.76
[Combined use of radioprotective compounds (review of literature)]. Farmakol Toksikol (1972) 0.76
[Comparative elimination of radiation-protective and toxic effects of cystamine]. Radiobiologiia (1971) 0.76
[Radiosensitivity of animals irradiated in an altered gaseous environment. 1. The effect of breathing normobaric pure oxygen during irradiation on body radioresistance and the antiradiation effectiveness of radioprotectors]. Radiobiologiia (1980) 0.76
[Comparative characteristics of the modification of radiosensitivity of mice and rats by a hypoxic mixture]. Radiobiologiia (1986) 0.76
Therapeutic effect of long-term melatonin treatment on the course and fatal outcome of modeled acute radiation sickness. Bull Exp Biol Med (2014) 0.76
[Radioprotective properties of indralin combined with cystamine and mexamine]. Radiats Biol Radioecol (2011) 0.76
Tobacco cell cultures transformed by the hsp 101 gene exhibit an increased resistance to potassium fluoride. Dokl Biol Sci (2010) 0.75
[Radiation protectors within the radiation safety system for extended duration exploration missions]. Aviakosm Ekolog Med (2011) 0.75
[Anti-radiation effectiveness of cystamine and mexamine on mouse hematopoietic stem cells in vivo]. Radiobiologiia (1977) 0.75
[The characteristic of radioprotective properties of a radioprotectant B-190 at its administration after radiation]. Radiats Biol Radioecol (2009) 0.75
[Changes in the therapeutic spectrum with respect to the pharmacological and radioprotective activity after O-alkylation of serotonin and 5(2-hydroxyethoxytryptamine)]. Radiobiologiia (1987) 0.75
[Effect of preliminary application of mexamine on its toxicity during repeated administration to irradiated and intact animals]. Radiobiologiia (1973) 0.75
[Change in the functional activity of the blood complement system after administration of adrenaline to animals]. Patol Fiziol Eksp Ter (1996) 0.75
[Antiradiation effectiveness of cystamine administered repeatedly before the action of gamma-irradiation]. Radiobiologiia (1973) 0.75
[Species-specific reactions of succinate dehydrogenase of lymphocytes in animals to acute hypoxic hypoxia and its relation to the radiation resistance of the body]. Kosm Biol Aviakosm Med (1989) 0.75
[Radiation-protective properties of o-acyl serotonin derivatives]. Radiobiologiia (1971) 0.75
[Kinetocardiography in the diagnosis of pulmonary artery stenosis]. Ter Arkh (1984) 0.75
[Radiation protective efficacy of alpha-adrenomimetics during local gamma irradiation of the skin]. Radiats Biol Radioecol (1999) 0.75
[Pigmented villonodular synovitis]. Arkh Patol (2011) 0.75
[Morphological manifestations of anthracycline cardiomyopathy in the ventricular myocardium of the rat]. Biull Eksp Biol Med (1987) 0.75
[Ultrastructural changes in the cardiomyocytes in protein synthesis disorders]. Arkh Patol (1983) 0.75
[Stereologic analysis of the myocardium in alcoholic cardiomyopathy]. Biull Eksp Biol Med (1989) 0.75
[Comparative evaluation of the glycosaminoglycan composition in plasma membranes of normal and transformed mouse liver cells]. Biokhimiia (1990) 0.75
[Anatomo-histologic characteristics of the epiphysis of the female silver fox outside the breeding season]. Arkh Anat Gistol Embriol (1985) 0.75
[The effect of ionizing radiation and immunomodulators on the development of the graft versus host reaction]. Radiobiologiia (1991) 0.75
[Electro- and phonocardiographic diagnosis of interatrial septal defect and pulmonary hypertension in patients over 20 years old]. Kardiologiia (1983) 0.75
[Molecular markers of the cervical cancer]. Vestn Ross Akad Med Nauk (2002) 0.75
Effect of radioprotector Indralin on the course of acute GVH disease. Bull Exp Biol Med (2008) 0.75
[Synovial lipoma arborescens]. Arkh Patol (2014) 0.75
[Seasonal changes in the testes of the silver fox]. Arkh Anat Gistol Embriol (1986) 0.75
[Myocardial infarction in systemic lupus erythematosus]. Klin Med (Mosk) (1993) 0.75
[Combined effect of normobaric hyperoxia and vibration on the radiosensitivity of animals]. Radiobiologiia (1987) 0.75
[Radiomodifying properties of the synthetic analog of prostaglandin F2 alpha-estrofan]. Radiobiologiia (1988) 0.75
[Hematopoietic cells of fetal liver. 1. Effect of growth factors of varying origin and activity of granulocyte-macrophage progenitor cells]. Gematol Transfuziol (1995) 0.75
[The phenomenon of cardiomyocyte disappearance in plastic insufficiency of the myocardium]. Biull Eksp Biol Med (1984) 0.75
[The morphological characteristics of osteoarthrosis]. Arkh Patol (2010) 0.75
Study of reactivity of the organism exposed to transverse accelerations and radioprotectants. Aerosp Med (1971) 0.75
[Radiation-protective properties of indolyl alkylaminoethanols]. Radiobiologiia (1972) 0.75
[Use of isosorbide dinitrate (isoket) in stenocardia and myocardial infarction]. Klin Med (Mosk) (1985) 0.75
[Pharmacological properties of radiation-protective agents. (Review)]. Farmakol Toksikol (1968) 0.75
[The influence of combined application of quercetin and indralin on post-irradiation repair of hematopoiesis in acute radiation injury]. Radiats Biol Radioecol (2011) 0.75
[Osteocartilaginous exostoses (osteochondromas)]. Arkh Patol (2008) 0.75
[Suppression of tumor growth in the liver by cis-diamminedichloroplatinum as large oligolamellar liposomes prepared by freezing and thawing]. Vopr Onkol (1989) 0.75
[Marfan's syndrome: polymorphism of its clinical manifestations]. Ter Arkh (1985) 0.75
[Adrenaline-induced damage to the myocardium in rats with genetically determined arterial hypertension]. Biull Eksp Biol Med (1985) 0.75
[Intraarticular chondromatosis]. Arkh Patol (2006) 0.75
[Experience in the treatment of suppurative wounds of traumatic origin with immobilized proteolytic enzymes]. Ortop Travmatol Protez (1984) 0.75
[Age-related changes in the cardiomyocyte population of the heart ventricles of white rats]. Ontogenez (1984) 0.75
[The cellular basis of myocardial contractile insufficiency]. Sov Med (1985) 0.75
[The diagnosis of Pneumocystis pneumonia (use of the Bauer reaction for detecting Pneumocystis carinii in pathological material]. Lab Delo (1991) 0.75
[Decrease in the antimetastatic effect of vinblastine administered in liposomes]. Eksp Onkol (1988) 0.75
[The effect of emotional stress on the hormonal status indices, the level of cyclic nucleotides and the content of beta 2-microglobulin in the blood and thymic tissue during the use of a synthetic analog of thyroliberin]. Patol Fiziol Eksp Ter (1990) 0.75
[Use of immobilized proteolytic enzymes in the treatment of postoperative pulmonary complications]. Anesteziol Reanimatol (1984) 0.75
[Outcome of idiopathic fibrosing alveolitis and its relation to indicators of pulmonary hemodynamics and respiration]. Probl Tuberk (1987) 0.75
[Amyloidosis in systemic lupus erythematosus]. Klin Med (Mosk) (1992) 0.75
[Operations on the adrenal glands in malignant hypertension]. Kardiologiia (1990) 0.75
[Pathomorphology of experimental pneumocystosis and cytogenesis of the pathogen Pneumocystis carinii]. Arkh Patol (1991) 0.75
[Course of the wound process during treatment with immobilized proteolytic enzymes]. Vestn Khir Im I I Grek (1983) 0.75
[Hemodynamics of the greater and lesser circulations in idiopathic fibrosing alveolitis]. Probl Tuberk (1984) 0.75
[Antiradiation properties of diserotonin esters of dicarboxylic acids]. Radiobiologiia (1974) 0.75
[Inherited hyperproduction of free radicals. The pathology of aging]. Dokl Akad Nauk (1994) 0.75
[Aneurysmal bone cyst in children]. Arkh Patol (2010) 0.75
[Radioprotective activity of new thiuronic derivatives]. Radiobiologiia (1973) 0.75
[Ultrastructural mechanisms of myocardial atrophy in white rats during starvation]. Biull Eksp Biol Med (1989) 0.75
[Biological effects of the electrical component of the superlong-wave electromagnetic field]. Izv Akad Nauk SSSR Biol (1983) 0.75
[Radiation-modifying effect of quinoline derivatives]. Radiobiologiia (1988) 0.75
[Endocarditis in systemic lupus erythematosus]. Klin Med (Mosk) (1996) 0.75
[Chondroblastoma of the skull base]. Zh Vopr Neirokhir Im N N Burdenko (2007) 0.75
[Significance of the tubulointerstitial and fibroplastic components of nephritis for the prognosis of kidney lesions in systemic lupus erythematosus]. Urol Nefrol (Mosk) (1986) 0.75